520 related articles for article (PubMed ID: 26732321)
1. Histopathology of breast cancer after magnetic resonance-guided high-intensity focused ultrasound and radiofrequency ablation.
Knuttel FM; Waaijer L; Merckel LG; van den Bosch MA; Witkamp AJ; Deckers R; van Diest PJ
Histopathology; 2016 Aug; 69(2):250-9. PubMed ID: 26732321
[TBL] [Abstract][Full Text] [Related]
2. The effects of Magnetic Resonance Imaging-guided High-Intensity Focused Ultrasound ablation on human cadaver breast tissue.
Merckel LG; Deckers R; Baron P; Bleys RL; van Diest PJ; Moonen CT; Mali WP; van den Bosch MA; Bartels LW
Eur J Pharmacol; 2013 Oct; 717(1-3):21-30. PubMed ID: 23583321
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
[TBL] [Abstract][Full Text] [Related]
4. MRI-guided treatment in the breast.
Pediconi F; Marzocca F; Cavallo Marincola B; Napoli A
J Magn Reson Imaging; 2018 Dec; 48(6):1479-1488. PubMed ID: 30318672
[TBL] [Abstract][Full Text] [Related]
5. First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation.
Merckel LG; Knuttel FM; Deckers R; van Dalen T; Schubert G; Peters NH; Weits T; van Diest PJ; Mali WP; Vaessen PH; van Gorp JM; Moonen CT; Bartels LW; van den Bosch MA
Eur Radiol; 2016 Nov; 26(11):4037-4046. PubMed ID: 26852219
[TBL] [Abstract][Full Text] [Related]
6. A clinically feasible treatment protocol for magnetic resonance-guided high-intensity focused ultrasound ablation in the liver.
Wijlemans JW; de Greef M; Schubert G; Bartels LW; Moonen CT; van den Bosch MA; Ries M
Invest Radiol; 2015 Jan; 50(1):24-31. PubMed ID: 25198833
[TBL] [Abstract][Full Text] [Related]
7. Use of cytokeratin 8 immunohistochemistry for assessing cell death after radiofrequency ablation of breast cancers.
Kreb DL; Bosscha K; Ernst MF; Rutten MJ; Jager GJ; van Diest PJ; van der Linden JC
Biotech Histochem; 2011 Dec; 86(6):404-12. PubMed ID: 20950219
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided radiofrequency ablation of early breast cancer in a resection specimen: lessons for further research.
Kreb DL; Looij BG; Ernst MF; Rutten MJ; Jager GJ; van der Linden JC; Pruijt JF; Bosscha K
Breast; 2013 Aug; 22(4):543-7. PubMed ID: 23228482
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation.
Sun Y; Zheng Y; Ran H; Zhou Y; Shen H; Chen Y; Chen H; Krupka TM; Li A; Li P; Wang Z; Wang Z
Biomaterials; 2012 Aug; 33(24):5854-64. PubMed ID: 22617321
[TBL] [Abstract][Full Text] [Related]
10. In vivo MR guided boiling histotripsy in a mouse tumor model evaluated by MRI and histopathology.
Hoogenboom M; Eikelenboom D; den Brok MH; Veltien A; Wassink M; Wesseling P; Dumont E; Fütterer JJ; Adema GJ; Heerschap A
NMR Biomed; 2016 Jun; 29(6):721-31. PubMed ID: 27061290
[TBL] [Abstract][Full Text] [Related]
11. Thermal ablation of a confluent lesion in the porcine kidney with a clinically available MR-HIFU system.
van Breugel JMM; de Greef M; Wijlemans JW; Schubert G; van den Bosch MAAJ; Moonen CTW; Ries MG
Phys Med Biol; 2017 Jul; 62(13):5312-5326. PubMed ID: 28557798
[TBL] [Abstract][Full Text] [Related]
12. MR-guided high-intensity focused ultrasound ablation of breast cancer with a dedicated breast platform.
Merckel LG; Bartels LW; Köhler MO; van den Bongard HJ; Deckers R; Mali WP; Binkert CA; Moonen CT; Gilhuijs KG; van den Bosch MA
Cardiovasc Intervent Radiol; 2013 Apr; 36(2):292-301. PubMed ID: 23232856
[TBL] [Abstract][Full Text] [Related]
13. Non-Invasive Targeted Peripheral Nerve Ablation Using 3D MR Neurography and MRI-Guided High-Intensity Focused Ultrasound (MR-HIFU): Pilot Study in a Swine Model.
Huisman M; Staruch RM; Ladouceur-Wodzak M; van den Bosch MA; Burns DK; Chhabra A; Chopra R
PLoS One; 2015; 10(12):e0144742. PubMed ID: 26659073
[TBL] [Abstract][Full Text] [Related]
14. Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy.
Hijnen NM; Elevelt A; Grüll H
Invest Radiol; 2013 Jul; 48(7):517-24. PubMed ID: 23695082
[TBL] [Abstract][Full Text] [Related]
15. "Wide local ablation" of localized breast cancer using high intensity focused ultrasound.
Wu F; Wang ZB; Cao YD; Zhu XQ; Zhu H; Chen WZ; Zou JZ
J Surg Oncol; 2007 Aug; 96(2):130-6. PubMed ID: 17443737
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonance-guided high intensity focused ultrasound-triggered release.
Oerlemans C; Nijsen F; van Amersfoort M; van Bloois L; Heijman E; Luijten P; Mali W; Storm G
Eur J Pharm Biopharm; 2011 Apr; 77(3):458-64. PubMed ID: 21195760
[TBL] [Abstract][Full Text] [Related]
17. Technical aspects of osteoid osteoma ablation in children using MR-guided high intensity focussed ultrasound.
Yarmolenko PS; Eranki A; Partanen A; Celik H; Kim A; Oetgen M; Beskin V; Santos D; Patel J; Kim PCW; Sharma K
Int J Hyperthermia; 2018 Feb; 34(1):49-58. PubMed ID: 28540807
[TBL] [Abstract][Full Text] [Related]
18. Toward MR-guided high intensity focused ultrasound for presurgical localization: focused ultrasound lesions in cadaveric breast tissue.
Bitton RR; Kaye E; Dirbas FM; Daniel BL; Pauly KB
J Magn Reson Imaging; 2012 May; 35(5):1089-97. PubMed ID: 22170814
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma.
Chan AC; Cheung TT; Fan ST; Chok KS; Chan SC; Poon RT; Lo CM
Ann Surg; 2013 Apr; 257(4):686-92. PubMed ID: 23426335
[TBL] [Abstract][Full Text] [Related]
20. Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities.
Guan L; Xu G
World J Surg Oncol; 2016 May; 14(1):153. PubMed ID: 27230124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]